Pathology & Laboratory Medicine

Publications

2005

Lepley D, Paik J-, Hla T, Ferrer F. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res. 2005;65(9):3788-95.
Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, et al. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res. 2005;11(6):2237-43.
Zhang J, Zhou P. Ectopic targeting of substrates to the ubiquitin pathway. Methods Enzymol. 2005;399:823-33.
Gorlova O, Peng B, Yankelevitz D, Henschke C, Kimmel M. Estimating the growth rates of primary lung tumours from samples with missing measurements. Stat Med. 2005;24(7):1117-34.
Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, et al. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. J Clin Oncol. 2005;23(24):5696-704.
Ferri C, Azzi A, Magro CM. Parvovirus B19 and systemic sclerosis. Br J Dermatol. 2005;152(4):819-20.
Varmus H, Pao W, Politi K, Podsypanina K, Du Y-. Oncogenes come of age. Cold Spring Harb Symp Quant Biol. 2005;70:1-9.
Patterson CC, Ross P, Pope-Harman AL, Knight DA, Magro CM. Alpha-1 anti-trypsin deficiency and Henoch-Schönlein purpura associated with anti-neutrophil cytoplasmic and anti-endothelial cell antibodies of immunoglobulin-A isotype. J Cutan Pathol. 2005;32(4):300-6.
Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, et al. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy. Leuk Lymphoma. 2005;46(4):541-7.
Sachdeva M, Frambach GE, A Crowson N, Deng AC, Mihm MC, Magro CM. De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients. J Cutan Pathol. 2005;32(9):622-8.
Directory News and Events Ways to Give Contact Us

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700